Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 2 (2005), Issue 3 (March)

1. MRI in treatment of adult gliomas.
   Lancet Oncol, 6(3): 167-75. [Abstract] [Full-text]
2. Radiation treatment for medulloblastoma: a review of 64 cases at a single institute.
   Jpn J Clin Oncol, 35(3): 111-5. [Abstract] [Full-text]
3. Intracranial ependymomas in childhood: recurrence, reoperation, and outcome.
   Childs Nerv Syst, 21(3): 221-6. [Abstract] [Full-text]
4. Specific AHNAK expression in brain endothelial cells with barrier properties.
   J Cell Physiol, 203(2): 362-71. [Abstract] [Full-text]
5. The use of neoadjuvant chemotherapy to achieve complete surgical resection in recurring supratentorial anaplastic ependymoma.
   Childs Nerv Syst, 21(3): 230-3. [Abstract] [Full-text]
6. Metastatic meningioma WHO grade II of the cervical spine: case report and review of the literature.
   Zentralbl Neurochir, 66(1): 35-8. [Abstract] [Full-text]
7. Immunohistochemical analysis of cleaved caspase-3 detects high level of apoptosis frequently in diffuse large B-cell lymphomas of the central nervous system.
   Pathol Int, 55(3): 122-9. [Abstract] [Full-text]
8. Advanced neuronavigation in skull base tumors and vascular lesions.
   Minim Invasive Neurosurg, 48(1): 13-8. [Abstract] [Full-text]
9. Long-term mobile phone use and brain tumor risk.
   Am J Epidemiol, 161(6): 526-35. [Abstract] [Full-text]
10. Direct infiltration of brainstem glioma along the cranial nerves.
    J Neuroimaging, 15(2): 197-9. [Abstract] [Full-text]
11. Correlation of VEGF production with IL1 alpha and IL6 secretion by human pituitary adenoma cells.
    Eur J Endocrinol, 152(2): 293-300. [Abstract] [Full-text]
12. Comparison of manual vs. automated multimodality (CT-MRI) image registration for brain tumors.
    Med Dosim, 30(1): 20-4. [Abstract] [Full-text]
13. An assessment of biologically-based optimization (BORT) in the IMRT era.
    Med Dosim, 30(1): 12-9. [Abstract] [Full-text]
14. Simulating the impact of a molecular 'decision-process' on cellular phenotype and multicellular patterns in brain tumors.
    J Theor Biol, 233(4): 469-81. [Abstract] [Full-text]
15. Hypoxia sensitizes human malignant glioma cells towards CD95L-induced cell death.
    J Neurochem, 92(6): 1340-9. [Abstract] [Full-text]
16. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo.
    Cancer Res, 65(5): 1934-40. [Abstract] [Full-text]
17. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma.
    Cancer Res, 65(5): 1678-86. [Abstract] [Full-text]
18. Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by means of intracarotid injection and blood-brain barrier disruption: quantitative iodine biodistribution studies and associated dosimetry.
    Int J Radiat Oncol Biol Phys, 61(4): 1173-82. [Abstract] [Full-text]
19. Characterization of two non-testis-specific CABYR variants that bind to GSK3beta with a proline-rich extensin-like domain.
    Biochem Biophys Res Commun, 329(3): 1108-17. [Abstract] [Full-text]
20. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance.
    Cancer, 103(6): 1227-33. [Abstract] [Full-text]
21. Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases.
    Cancer, 103(6): 1234-44. [Abstract] [Full-text]
22. Spurious leptomeningeal enhancement on immediate post-operative MRI for paediatric brain tumours.
    Pediatr Radiol, 35(3): 334-8. [Abstract] [Full-text]
23. Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study.
    Br J Cancer, 92(5): 815-9. [Abstract] [Full-text]
24. MGMT gene silencing and benefit from temozolomide in glioblastoma.
    N Engl J Med, 352(10): 997-1003. [Abstract] [Full-text]
25. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
    N Engl J Med, 352(10): 987-96. [Abstract] [Full-text]
26. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.
    N Engl J Med, 352(10): 978-86. [Abstract] [Full-text]
27. FSH secretion predominates in vivo and in vitro in patients with non-functioning pituitary adenomas.
    Eur J Endocrinol, 152(3): 363-70. [Abstract] [Full-text]
28. The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy.
    J Clin Endocrinol Metab, 90(3): 1542-9. [Abstract] [Full-text]
29. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia. Part II: Application of the thermal equivalency equation.
    Int J Hyperthermia, 21(1): 13-27. [Abstract] [Full-text]
30. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection relative to hyperthermia.
    Int J Hyperthermia, 21(1): 1-11. [Abstract] [Full-text]
31. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
    Eur J Cancer, 41(5): 727-34. [Abstract] [Full-text]
32. Intracranial angiolipoma as cause of subarachnoid haemorrhage. Case report and review of the literature.
    Neuroradiology, 47(2): 91-6. [Abstract] [Full-text]
33. Intermediate filament protein synemin is present in human reactive and malignant astrocytes and associates with ruffled membranes in astrocytoma cells.
    Glia, 50(2): 107-20. [Abstract] [Full-text]
34. Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16.
    Mol Cancer Ther, 4(3): 343-9. [Abstract] [Full-text]
35. Prior hospitalization for epilepsy, diabetes, and stroke and subsequent glioma and meningioma risk.
    Cancer Epidemiol Biomarkers Prev, 14(3): 643-50. [Abstract] [Full-text]
36. Unusual cause of visual symptoms after bilateral laser in situ keratomileusis.
    J Cataract Refract Surg, 31(2): 446-9. [Abstract] [Full-text]
37. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
    Clin Radiol, 60(4): 493-502. [Abstract] [Full-text]
38. Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up--recommendations in KRANIOPHARYNGEOM 2000.
    Onkologie, 28(3): 150-6. [Abstract] [Full-text]
39. Discovery of a perinecrotic 60 kDa MDM2 isoform within glioma spheroids and glioblastoma biopsy material.
    Neuropathol Appl Neurobiol, 31(2): 191-202. [Abstract] [Full-text]
40. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.
    Cancer Sci, 96(3): 183-90. [Abstract] [Full-text]
41. Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy.
    Cancer Sci, 96(3): 149-56. [Abstract] [Full-text]
42. Facets and determinants of quality of life in patients with recurrent high grade glioma.
    J Neurol Neurosurg Psychiatry, 76(4): 562-8. [Abstract] [Full-text]
43. Views of bereaved relatives about quality of survival after radiotherapy for malignant cerebral glioma.
    J Neurol Neurosurg Psychiatry, 76(4): 555-61. [Abstract] [Full-text]
44. Intravascular lymphoma: magnetic resonance imaging correlates of disease dynamics within the central nervous system.
    J Neurol Neurosurg Psychiatry, 76(4): 540-4. [Abstract] [Full-text]
45. Emergency craniotomy in patients with intracranial metastatic gestational trophoblastic tumor.
    Int J Gynaecol Obstet, 89(1): 35-8. [Abstract] [Full-text]
46. Imaging of central nervous system lymphomas with iodine-123 labeled rituximab.
    Eur J Haematol, 74(4): 348-52. [Abstract] [Full-text]
47. Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas.
    Lab Invest, 85(4): 464-73. [Abstract] [Full-text]
48. Common genetic changes in hereditary and sporadic pituitary adenomas detected by comparative genomic hybridization.
    Genes Chromosomes Cancer, 43(1): 72-82. [Abstract] [Full-text]
49. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation.
    Cancer Res, 65(6): 2353-63. [Abstract] [Full-text]
50. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
    Cancer Res, 65(6): 2065-9. [Abstract] [Full-text]
51. The use of multivariate MR imaging intensities versus metabolic data from MR spectroscopic imaging for brain tumour classification.
    J Magn Reson, 173(2): 218-28. [Abstract] [Full-text]
52. Early brain lesions and face-processing development.
    Dev Psychobiol, 46(3): 184-208. [Abstract] [Full-text]
53. Bilateral peripapillary subretinal neovessel membrane associated with chronic papilledema: report of two cases.
    Klin Monatsbl Augenheilkd, 222(3): 275-8. [Abstract] [Full-text]
54. Primary sellar esthesioneuroblastoma.
    Acta Neurochir (Wien), 147(4): 447-8; discussion 448. [Abstract] [Full-text]
55. Morphology of tumor cell nuclei is significantly related with survival time of patients with glioblastomas.
    Clin Cancer Res, 11(6): 2141-8. [Abstract] [Full-text]
56. Homozygosity mapping of familial glioma in Northern Sweden.
    Acta Oncol, 44(2): 114-9. [Abstract] [Full-text]
57. Linac radiosurgery as a tool in neurosurgery.
    Neurosurg Rev, 28(2): 79-88; discussion 89-90, 91. [Abstract] [Full-text]
58. New insights into the anatomo-functional connectivity of the semantic system: a study using cortico-subcortical electrostimulations.
    Brain, 128: 797-810. [Abstract] [Full-text]
59. Variability in infectivity of primary cell cultures of human brain tumors with HSV-1 amplicon vectors.
    Gene Ther, 12(7): 588-96. [Abstract] [Full-text]
60. Surgical treatment for brain metastases: prognostic factors and survival in 177 patients.
    Neurosurg Rev, 28(2): 115-9. [Abstract] [Full-text]
61. 201Tl-SPECT and 1H-MRS study of benign lateral ventricle tumors: differential diagnosis of subependymoma.
    Neurosurg Rev, 28(2): 96-103. [Abstract] [Full-text]
62. Solitary cerebral metastases from ovarian epithelial carcinoma: 11 cases.
    Neurosurg Rev, 28(2): 120-3. [Abstract] [Full-text]
63. Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival.
    Acta Neuropathol (Berl), 109(2): 211-6. [Abstract] [Full-text]
64. Ependymoma with neuropil-like islands: a case report with diagnostic and histogenetic implications.
    Acta Neuropathol (Berl), 109(2): 231-4. [Abstract] [Full-text]
65. Residential and occupational exposure to 50-Hz magnetic fields and brain tumours in Norway: a population-based study.
    Int J Cancer, 115(1): 137-41. [Abstract] [Full-text]
66. An improved methodology for modeling neurobehavioral late-effects of radiotherapy in pediatric brain tumors.
    Pediatr Blood Cancer, 44(5): 487-93. [Abstract] [Full-text]
67. RNA expression analysis of a congenital intracranial teratoma.
    Pediatr Blood Cancer, 44(5): 516-20. [Abstract] [Full-text]
68. Akt-dependent cell size regulation by the adhesion molecule on glia occurs independently of phosphatidylinositol 3-kinase and Rheb signaling.
    Mol Cell Biol, 25(8): 3151-62. [Abstract] [Full-text]
69. Bacterial endotoxin (lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the toll-like receptor 4.
    J Neuroendocrinol, 17(3): 152-60. [Abstract] [Full-text]
70. ROC analysis as an additional method to characterize time to event data.
    Pathol Oncol Res, 11(1): 50-2. [Abstract] [Full-text]
71. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis.
    J Clin Oncol, 23(10): 2411-22. [Abstract] [Full-text]
72. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
    J Clin Oncol, 23(10): 2372-7. [Abstract] [Full-text]
73. Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood.
    J Clin Oncol, 23(10): 2256-63. [Abstract] [Full-text]
74. Pediatric brain MRI in neurofibromatosis type I.
    Eur Radiol, 15(4): 814-22. [Abstract] [Full-text]

© 2004-2008 Brain Cancer Research Today. All Rights Reserved.